Skip to content

LIMN

Liminatus Pharma, Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.11
+2.30%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
13.90x
Price / sales
—
Price / cash flow
-1.05x

Enterprise value

Enterprise value
$2.6M
EV / sales
—
EV / EBITDA
-0.21x
EV / EBIT
-0.64x
Market cap
$4.2M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026